In addition, it was the first report that Chelerythrine promoted apoptosis and inhibited proliferation by regulating the expression of estrogen receptors in gastric cancer cells, highlighting the potential use of JAK inhibitors as therapeutic candidates by mediating estrogen receptors. The gene discussed is ESR1; the disease is gastric cancer.